MARAVAI LIFE SCIENCES
Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.
MARAVAI LIFE SCIENCES
Social Links:
Industry:
Biotechnology Health Care
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.maravai.com
Total Employee:
51+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
1000 M USD
Technology used in webpage:
Viewport Meta SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager Content Delivery Network Global Site Tag Microsoft Exchange Online
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Ansun BioPharma
Ansun BioPharma is a clinical-stage biopharmaceutical company focused on the development of host-directed anti-viral.
Gelesis
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients.
Homology Medicines
Homology Medicines is a genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases.
Medicago
Medicago is a biotechnology company focused on the research, development, production, and commercialization of vaccines in Canada.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tandem Diabetes Care
Tandem diabetes care provides products that empower both people with diabetes and those who care for them.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-01-28 | MyChem | MyChem acquired by Maravai Life Sciences | 240 M USD |
| 2018-01-03 | Glen Research Corp. | Glen Research Corp. acquired by Maravai Life Sciences | N/A |
| 2016-10-26 | TriLink BioTechnologies | TriLink BioTechnologies acquired by Maravai Life Sciences | N/A |
| 2016-10-26 | Cygnus Technologies | Cygnus Technologies acquired by Maravai Life Sciences | N/A |
Investors List
GTCR
GTCR investment in Private Equity Round - Maravai Life Sciences
Key Employee Changes
| Date | New article |
|---|---|
| 2020-02-11 | Maravai LifeSciences Hires Two Senior Executives for TriLink BioTechnologies |
Official Site Inspections
http://www.maravai.com Semrush global rank: 2.99 M Semrush visits lastest month: 5.43 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Maravai Life Sciences"
Maravai LifeSciences
Maravai’s brands are the proven catalysts for helping biotech, biopharma, and life science companies across the globe to realize the next generation of novel vaccines, therapeutics, and …See details»
Maravai LifeSciences Holdings, Inc. (MRVI)
Oct 15, 2024 · Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support research on human diseases.See details»
Who we are - Maravai LifeSciences
Nov 12, 2024 · For over 35 years, Maravai’s portfolio of brands have served as a catalyst for innovative, lifesaving technology for humanity. We have been a key player in nucleotide …See details»
Meet Maravai: Where extraordinary science ... - Maravai LifeSciences
Maravai’s approach to innovation empowers and encourages its partners to innovate in everything they do. From getting to first-in-human or first-in-market, whether powering personalized …See details»
Maravai Life Sciences - Crunchbase Company Profile
Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines. View contacts for Maravai Life Sciences to access new leads and connect with decision-makers.See details»
Maravai LifeSciences Holdings, Inc. (MRVI) - Yahoo Finance
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human...See details»
Maravai LifeSciences - LinkedIn
From producing revolutionary mRNA technologies that drive infectious disease vaccines, cancer vaccines, and other cell and gene therapies to delivering gold-standard bioprocess impurity detection...See details»
Company information - Maravai LifeSciences Holdings, …
Maravai LifeSciences is a leading life sciences company providing critical products to enable the development of novel vaccines, drug therapies, and diagnostics, and to support research on human diseases.See details»
Our impact - Maravai LifeSciences
ESG is core to achieving our long-term objectives, which is why we have an executive leader dedicated to ESG, measure our environmental footprint and have implemented new processes to increase data collection and enhance …See details»
Maravai LifeSciences Holdings | MRVI Stock Price, Company
Maravai LifeSciences enables the development of drug therapies, diagnostics and novel vaccines and supports research on human diseases through its portfolio of market-leading companies …See details»
ESG :: Maravai LifeSciences Holdings, Inc. (MRVI)
Our commitment to ESG is enterprise-wide and connects every individual across our organization. Our ESG practices are fundamental to realizing our vision of a world where scientists are limited only by the boundaries of their imaginations …See details»
Maravai LifeSciences Holdings, Inc. (MRVI) - Yahoo Finance
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human …See details»
Maravai LifeSciences Announces Establishment of New Charitable …
Dec 9, 2021 · Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, and novel vaccines and to support research on …See details»
Supply chain - Maravai LifeSciences
At Maravai, we pride ourselves on our robust and agile supply chain strategy. With a relentless focus on quality, reliability, and efficiency, we ensure consistent access to our brands’ broad …See details»
Maravai LifeSciences: The Future Beyond Covid Vaccines - Seeking …
Jun 29, 2021 · Maravai LifeSciences Holdings, Inc. (NASDAQ: NASDAQ: MRVI) is a leading life sciences company developing and providing critical products for new drug development, …See details»
Maravai LifeSciences Announces Establishment of New Charitable ...
SAN DIEGO, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to …See details»
Maravai LifeSciences: Still Struggling To Find Its Footing
3 days ago · Maravai LifeSciences Holdings, Inc. is headquartered in San Diego, CA. This life sciences concern main focus is supplying a reliable supply of reagents in the fields of nucleic …See details»
Diversity, equity, and inclusion - Maravai LifeSciences
At Maravai LifeSciences, we embrace Diversity, Equity, and Inclusion (DEI) as a cornerstone of our organizational culture and success. We firmly believe that diversity is not only a reflection …See details»
Maravai Stock: Two Elite Assets With Other-Worldly Margins …
Maravai first hit public markets in late 2020 on the heels of its phenomenal success in helping the Pfizer/BioNTech (/) mRNA vaccine approach commercial launch. Maravai was formed as a …See details»
Innovation - Maravai LifeSciences
For over 35 years, Maravai’s portfolio companies have served as a catalyst for innovative, lifesaving technology for humanity. Pioneering nucleotide research since its inception, we are …See details»